comparemela.com

Latest Breaking News On - Hillstream biopharma - Page 1 : comparemela.com

Hillstream BioPharma (NASDAQ:HILS) Shares Down 7 2%

Hillstream BioPharma, Inc. (NASDAQ:HILS – Get Free Report)’s share price traded down 7.2% during trading on Thursday . The company traded as low as $4.42 and last traded at $4.49. 29,732 shares traded hands during trading, a decline of 98% from the average session volume of 1,388,685 shares. The stock had previously closed at $4.84. […]

Histone Deacetylase 6 Drug Pipeline Research Report 2024:

Hillstream BioPharma (NASDAQ:HILS) Stock Price Down 6 6%

Hillstream BioPharma, Inc. (NASDAQ:HILS – Get Free Report) dropped 6.6% during mid-day trading on Friday . The company traded as low as $0.43 and last traded at $0.44. Approximately 482,816 shares changed hands during mid-day trading, a decline of 65% from the average daily volume of 1,388,685 shares. The stock had previously closed at $0.47. […]

Tharimmune (THAR) versus Its Peers Financial Comparison

Tharimmune (NASDAQ:THAR – Get Free Report) is one of 913 public companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its competitors? We will compare Tharimmune to similar companies based on the strength of its analyst recommendations, risk, profitability, institutional ownership, dividends, valuation and earnings. Profitability This table compares Tharimmune […]

Cary biotech startup lands licensing deal for potential chronic itchy skin treatment

Avior Bio, a small Cary startup developing a treatment for pruritus, or chronic itchy skin, has secured an agreement to license its clinical-stage therapy to a New Jersey pharmaceutical company.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.